SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jaesuk Yun, Eun Hwangbo, Jongpill Lee, Chong-Run Chon, Peol A. Kim, In-Hye Jeong, Manyoung Park, Raewoong Park, Shin-Jung Kang, Donwoong Choi, Analysis of an ECG Record Database Reveals QT Interval Prolongation Potential of Famotidine in a Large Korean Population, Cardiovascular Toxicology, 2015, 15, 2, 197

    CrossRef

  2. 2
    Rashmi R. Shah, Joel Morganroth, Robert B. Kleiman, ICH E14 Q&A(R2) document: commentary on the further updated recommendations on thorough QT studies, British Journal of Clinical Pharmacology, 2015, 79, 3
  3. 3
    Michael G. Fradley, Javid Moslehi, QT Prolongation and Oncology Drug Development, Cardiac Electrophysiology Clinics, 2015, 7, 2, 341

    CrossRef

  4. 4
    Louise Brygger, Jørn Herrstedt, 5-Hydroxytryptamine3receptor antagonists and cardiac side effects, Expert Opinion on Drug Safety, 2014, 13, 10, 1407

    CrossRef

  5. 5
    Yves Donazzolo, Mathilde Latreille, Marie-Anne Caillaud, Elisabeth Mocaer, Laure Seguin, Evaluation of the Effects of Therapeutic and Supratherapeutic Doses of Agomelatine on the QT/QTc Interval, Journal of Cardiovascular Pharmacology, 2014, 64, 5, 440

    CrossRef

  6. 6
    Nicolas Lindegger, Patricia N. Sidharta, Kathrin Reseski, Jasper Dingemanse, Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects, Pulmonary Pharmacology & Therapeutics, 2014, 29, 1, 41

    CrossRef

  7. 7
    Arash Sadrieh, Luke Domanski, Joe Pitt-Francis, Stefan A Mann, Emily C Hodkinson, Chai-Ann Ng, Matthew D Perry, John A Taylor, David Gavaghan, Rajesh N Subbiah, Jamie I Vandenberg, Adam P Hill, Multiscale cardiac modelling reveals the origins of notched T waves in long QT syndrome type 2, Nature Communications, 2014, 5, 5069

    CrossRef